Novo cashes in FDA national priority voucher for extra-speedy review of high-dose Wegovy
26th November 2025 Uncategorised 0The company filed its bid for a 7.2 mg Wegovy formulation using its National Priority Voucher from the FDA, which promises to accelerate a regulatory review to around one to two months.
More: Novo cashes in FDA national priority voucher for extra-speedy review of high-dose Wegovy
Source: fierce